Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as part of the pineal bioregulator series. It mimics the active core of natural pineal peptides that decline with age, promoting neuronal survival, BDNF expression, and epigenetic regulation in brain tissue. Widely used in Russian medicine for cognitive impairment, sleep disorders, and neuroprotection, it is a key tool for longevity and brain health research. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation.
Key Scientific
- High-purity Pinealon (≥ 99% by HPLC/MS, acetate salt form)
- Verified tripeptide sequence: Glu-Asp-Arg (EDR)
- Lyophilized formulation for maximum long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis
- Manufactured in GMP-aligned, ISO-compliant facilities
- Ideal for neuroprotection, BDNF modulation, and pineal/circadian research
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
- Protects brain cells from hypoxia and oxidative stress; increases neuron survival in culture models
- Normalizes pineal function and melatonin secretion in aged animals
- Improves cognitive parameters (memory, attention) in elderly and stress models
- Reduces age-related epigenetic changes and supports hippocampal neurogenesis
- Potential in Alzheimer’s, Parkinson’s, stroke recovery, and sleep disorder research
- High blood-brain barrier penetration; active via oral, nasal, or parenteral routes
Why Researchers Choose Nationwide Peptides Pinealon
- Exact Khavinson-sequence match used in 30+ years of Russian bioregulator studies
- Highest documented neuroprotective potency among pineal peptides
- Transparent analytical data (HPLC >99%, MS confirmation)
- Trusted by neurology, gerontology, and cognitive science laboratories
- Competitive research pricing with bulk options